RASSF1A Expression and Methylation in Gastric Cancer
Author Information
Author(s): Ye Mei, Xia Bing, Guo Qiusha, Zhou Feng, Zhang Xiaolian
Primary Institution: Wuhan University
Hypothesis
The study aims to investigate the relationship between RASSF1A expression and its promoter methylation in primary gastric cancer in Chinese patients.
Conclusion
RASSF1A expression is significantly reduced in gastric cancer tissues and is associated with increased promoter methylation.
Supporting Evidence
- RASSF1A mRNA expression in gastric cancer tissues was significantly lower than in adjacent normal tissues.
- The methylation frequency of RASSF1A in gastric cancer was 66.7%, compared to 14.8% in normal tissues.
- RASSF1A protein expression was only 21.4% of that in normal tissues.
Takeaway
This study found that a gene called RASSF1A, which helps prevent cancer, is not working well in stomach cancer because it is often turned off by a process called methylation.
Methodology
The study analyzed RASSF1A mRNA and protein expression in gastric cancer tissues compared to normal tissues using RT-PCR and Western blotting, and assessed methylation status using methylation-specific PCR.
Potential Biases
Potential bias due to the selection of patients from a single hospital.
Limitations
The study's sample size is limited, and the findings may not be generalizable to all gastric cancer patients.
Participant Demographics
The study included 54 patients, 35 males and 19 females, with a mean age of 57.6 years.
Statistical Information
P-Value
<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website